Mechanisms of spinal stiffening after growing rod insertion
Active Grant Awarded
- Award ID
- K23AR086373
- Recipient
-
The Children's Hospital Of Philadelphia UEI G7MQPLSUX1L4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $159,516
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date 3% complete
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services National Institutes of Health awarded The Children's Hospital of Philadelphia $159,516 on September 23, 2026, under Assistance Listing 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, through the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The program supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, along with training of basic and clinical scientists.
This K23 mentored patient-oriented research career development grant funds a series of multicenter translational studies. The work will validate the clinical features of autofusion, the premature spinal stiffening that can follow distraction-based growing rod insertion in early onset scoliosis, and define its natural history. The studies will also characterize autofusion using patient samples to define pathological mechanisms and establish an autofusion animal model. The research serves as a training vehicle for a double fellowship-trained pediatric orthopaedic spine surgeon, providing hands-on laboratory experience, experimental design, high-throughput -omics approaches, data analysis, animal procedural experience, and biostatistics under named mentors.
The period of performance runs from September 23, 2026 through August 31, 2031. Place of performance is Philadelphia, Pennsylvania 19104. The recipient's Research Institute division is the awardee of record.
Description
- Abstract
- Early onset scoliosis (EOS) is a significant medical condition affecting approximately 25,000 children globally each year. With an 84% complication rate and average treatment costs of $150,000 over six years, EOS imposes a tremendous burden on patients and their families due to frequent medical visits and surgeries required until skeletal maturity. The most common surgical intervention is distraction-based growing rods, designed to allow sequential spine lengthening. While effective in some cases, the spine may prematurely stiffen, which is known as autofusion, which occurs in up to 90% of patients within five years. This condition limits thoracic height, diminishes lung capacity, and reduces quality of life. Current understanding of the pathoanatomic and molecular mechanisms underlying autofusion is limited, hindering the development of preventative strategies. Imaging studies suggest potential changes such as increased disc stiffness and facet joint fusion, but these lack specificity. In this K23 mentored patient-oriented research career development award proposal, I, a double fellowship- trained pediatric orthopaedic spine surgeon, propose a series of multicenter translational studies to validate the clinical features of autofusion and define the natural history of autofusion, characterize autofusion using patient samples to define the pathological mechanisms, and establish an autofusion animal model. This research will serve as a training vehicle for hands-on laboratory experience, experimental design, high- throughput -omics approaches, data analysis, animal procedural experience, and biostatistics, under the guidance of renowned mentors in spine and musculoskeletal biology, including DRS. Simon tang, lori setton, matthew silva, burel goodin, munish gupta, and brian snyder. Career development mentors such as DRS. Farsh guilak, regis O'keefe, lindley wall, robert brophy, and jonathan schoenecker will advise me on establishing a successful career as an extramurally funded surgeon-scientist investigator. Additionally, I will engage in formal didactic coursework at the washington university school of medicine institute of clinical and translational sciences, working towards a master of science in clinical investigation.
Quick answers
Who received award K23AR086373?
K23AR086373 was awarded to The Children's Hospital Of Philadelphia by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 23, 2026.
How much is award K23AR086373 worth?
$159,516 has been obligated on K23AR086373.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award